Cytotoxic Chemotherapy in Advanced Pancreatic Cancer. [Review] (Record no. 280)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01756nam a22003497a 4500 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 221018s20222022 xxu||||| |||| 00| 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 0889-8588 |
| 024 ## - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1016/j.hoc.2022.07.006 [doi] |
| 024 ## - OTHER STANDARD IDENTIFIER | |
| Standard number or code | S0889-8588(22)00074-0 [pii] |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | Ovid MEDLINE(R) |
| 099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC) | |
| PMID | 36154782 |
| 245 ## - TITLE STATEMENT | |
| Title | Cytotoxic Chemotherapy in Advanced Pancreatic Cancer. [Review] |
| 251 ## - Source | |
| Source | Hematology - Oncology Clinics of North America. 2022 Sep 22 |
| 252 ## - Abbreviated Source | |
| Abbreviated source | Hematol Oncol Clin North Am. 2022 Sep 22 |
| 253 ## - Journal Name | |
| Journal name | Hematology/oncology clinics of North America |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Year | 2022 |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Manufacturer | FY2023 |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Publication date | 2022 Sep 22 |
| 265 ## - SOURCE FOR ACQUISITION/SUBSCRIPTION ADDRESS [OBSOLETE] | |
| Publication status | aheadofprint |
| 266 ## - Date added to catalog | |
| Date added to catalog | 2022-10-20 |
| 520 ## - SUMMARY, ETC. | |
| Abstract | Advanced pancreatic cancer remains one of the deadliest malignancies in 2022. Although there has been significant progress in treatment options with improved outcomes in many cancers, this growth has been slow in pancreatic cancer. This article examines specific components of approved first- and second-line therapies for advanced pancreatic cancer treatment and their effectiveness and concludes with a brief exploration of future directions for targeted therapies. Copyright © 2022 Elsevier Inc. All rights reserved. |
| 546 ## - LANGUAGE NOTE | |
| Language note | English |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | IN PROCESS -- NOT YET INDEXED |
| 656 ## - INDEX TERM--OCCUPATION | |
| Department | Hematology & Oncology Fellowship |
| 656 ## - INDEX TERM--OCCUPATION | |
| Department | MedStar Georgetown University Hospital/MedStar Washington Hospital Center |
| 657 ## - INDEX TERM--FUNCTION | |
| Medline publication type | Journal Article |
| 657 ## - INDEX TERM--FUNCTION | |
| Medline publication type | Review |
| 700 ## - ADDED ENTRY--PERSONAL NAME | |
| Local Authors | Rehman, Muneeb |
| Institution Code | MGUH |
| Program | Hematology & Oncology Fellowship |
| Degree | MD |
| Resident year | Fellow PGY 6 |
| 790 ## - Authors | |
| All authors | Khaled A, Noel M, Rehman M |
| 856 ## - ELECTRONIC LOCATION AND ACCESS | |
| DOI | <a href="https://dx.doi.org/10.1016/j.hoc.2022.07.006">https://dx.doi.org/10.1016/j.hoc.2022.07.006</a> |
| Public note | https://dx.doi.org/10.1016/j.hoc.2022.07.006 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Koha item type | Journal Article |
| Item type description | Article |
| Withdrawn status | Lost status | Damaged status | Not for loan | Collection | Home library | Current library | Date acquired | Total Checkouts | Full call number | Barcode | Date last seen | Price effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MedStar Authors Catalog | MedStar Authors Catalog | 10/20/2022 | 36154782 | 36154782 | 10/20/2022 | 10/20/2022 | Journal Article |